President Bush Signs Drug User Fee Bill

Law360, New York (September 27, 2007, 12:00 AM EDT) -- President George W. Bush signed legislation Thursday that renews the U.S. Food and Drug Administration's ability to charge fees for considering drugs for approval, alters the citizen petition process for generic drugs and strengthens drug safety.

However, some were disappointed that provisions to allow generic versions of biologic drugs or follow-on protein products get to market were not included. The bill also did not lower the current six-month pediatric exclusivity allowance to three months for blockbuster drugs, as a provision of the U.S. Senate version of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.